Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03233854
Title CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Crystal Mackall, MD
Indications

B-cell acute lymphoblastic leukemia

Therapies

Cyclophosphamide + Fludarabine

CD19/CD22 CAR T cells

NKTR-255

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.